Medical Product Investor Prospectus
HED: What Current Medical Research Says About “MAP” Bacteria—and why it matters to patients who suffer from Crohn’s and other diseases traditionally considered autoimmune
Virtually every patient diagnosed with Crohn’s Disease, Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Ulcerative Colitis, type 1 diabetes mellitus, Systemic Lupus Erythematosus, Complex Regional Pain Syndrome and other debilitating disorders has heard the term “autoimmune disease” used to describe their illness.But what, exactly, is an autoimmune disease? And how effective are conventional pharmaceutical-based therapies in treating them?
Medically speaking, the term autoimmune disease (AI) is simply a categorical, rather than a specific clinical description for roughly 80 different disorders that affect about 50 million Americans and tens of millions more worldwide. AI disorders develop when the body’s immune system attacks healthy body cells. The resulting symptoms can range from relatively modest (for example, mild psoriasis) to cripplingly painful—as in cases for many patients who suffer from Crohn’s Disease, Rheumatoid Arthritis and other chronic illnesses.
Unfortunately, this categorical description of so many different disorders with so many diverse and debilitating symptoms masks a simple medical fact: We don’t know with certainty what actually causes AI disorders. Thus, autoimmune disease has become a catch-all term, used to classify a dismayingly wide range of disorders with an equally discouragingly large number and variety of symptoms…